Csl Behring

Pic:gettyismagilov

EU approves first gene therapy for hemophilia B

By Jonathan Smith

Three months after receiving the US green light, CSL’s candidate Hemgenix has become the first gene therapy to gain EU approval for the treatment of hemophilia B.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All